Clinical Trial

Periodic Continuous Glucose Monitoring in Patients With Type 2 Diabetes

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this randomised controlled trial is to investigate the effectiveness of periodic CGM (continuous glucose monitoring) to support a person-centered approach versus self-monitoring of blood glucose (SMBG) in adults with type 2 diabetes on glucose control and patient reported outcomes.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-11-21; most recent amendment 2026-04-23.
Status change: Enrolling by Invitation → Recruiting 2023-03-24
Status change: Not Yet Recruiting → Enrolling by Invitation 2023-02-06
Trial Details
NCT Number NCT05633628
Lead Sponsor Sophiahemmet University
Collaborators: Swedish Diabetes Foundation, OneTwo Analytics AB, Sophiahemmet
Conditions Type 2 Diabetes
Enrollment 400 participants
Start Date 2023-02-01
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-29